The Role of Interferon- α in Neurodegenerative Diseases: A Systematic Review
Journal of Alzheimer’s Disease · 25.07.2023 · 94 (s1) · S45-S66
DOI: 10.3233/jad-221081 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 06.02.2023. Verfasst von Brendan Su Mee Hui und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical School Johor Bahru, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Johor Baru, Johor, Malaysia. Hauptthemen laut MEDLINE: Neurodegenerative Diseases. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Neurodegenerative diseases (NDs) impose significant financial and healthcare burden on populations all over the world. The prevalence and incidence of NDs have been observed to increase dramatically with age. Hence, the number of reported cases is projected to increase in the future, as life spans continues to rise. Despite this, there is limited effective treatment against most NDs. Interferons (IFNs), a family of cytokines, have been suggested as a promising therapeutic target for NDs, particularly IFN- α, which governs various pathological pathways in different NDs.
Objective
This systematic review aimed to critically appraise the currently available literature on the pathological role of IFN- α in neurodegeneration/NDs.
Methods
Three databases, Scopus, PubMed, and Ovid Medline, were utilized for the literature search.
Results
A total of 77 journal articles were selected for critical evaluation, based on the inclusion and exclusion criteria. The studies selected and elucidated in this current systematic review have showed that IFN- α may play a deleterious role in neurodegenerative diseases through its strong association with the inflammatory processes resulting in mainly neurocognitive impairments. IFN- α may be displaying its neurotoxic function via various mechanisms such as abnormal calcium mineralization, activation of STAT1-dependent mechanisms, and increased quinolinic acid production.
Conclusion
The exact role IFN- α in these neurodegenerative diseases have yet to be determine due to a lack in more recent evidence, thereby creating a variability in the role of IFN- α. Future investigations should thus be conducted, so that the role played by IFN- α in neurodegenerative diseases could be delineated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical School Johor Bahru, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Johor Baru, Johor, Malaysia.
- Neuropharmacology Research Laboratory, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia.
- School of Science, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia.
- School of Dentistry and Medical Sciences, Charles Sturt University, Orange, NSW, Australia.
- Department of Neuroscience, Central Clinical School, Monash University, The Alfred Hospital, Melbourne, VIC, Australia.
Zitieren
APA
Hui, B. S. M., Zhi, L. R., Retinasamy, T., Arulsamy, A., Law, C. S. W., Shaikh, M. F., & Yeong, K. Y. (2023). The Role of Interferon- α in Neurodegenerative Diseases: A Systematic Review. Journal of Alzheimer’s Disease, 94(s1), S45-S66. https://doi.org/10.3233/jad-221081
Vancouver
Hui BSM, Zhi LR, Retinasamy T, Arulsamy A, Law CSW, Shaikh MF, et al. The Role of Interferon- α in Neurodegenerative Diseases: A Systematic Review. Journal of Alzheimer’s Disease. 2023;94(s1):S45-S66. doi:10.3233/jad-221081
BibTeX
@article{Hui2023,
author = {Hui, Brendan Su Mee and Zhi, Lee Rui and Retinasamy, Thaarvena and Arulsamy, Alina and Law, Christine Shing Wei and Shaikh, Mohd Farooq and Yeong, Keng Yoon},
title = {The Role of Interferon- α in Neurodegenerative Diseases: A Systematic Review},
journal = {Journal of Alzheimer’s Disease},
year = {2023},
volume = {94},
number = {s1},
pages = {S45--S66},
doi = {10.3233/jad-221081}
}
EUVIMED